AMEX
12.69USD
-0.01 (-0.08%)
We have scored 12 news catalysts on InfuSystem Holdings, Inc. (INFU) over the past 12 months. The biggest single-day move next to one of them came Aug 4, 2026, when INFU closed +33.6%: “InfuSystems Holdings, Inc. (INFU) Q2 Earnings and Revenues Surpass Estimates”. Coverage across the window leans positive (average ticker sentiment +0.69). Most of the impact sits in sector healthcare and institutional appeal.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
256.1M
P/E
—
EPS
—
Beta
1.50
52W range
7.29-13.2
Day range
12.50–12.86
Open
12.75
Prev close
12.70
Volume
109.1K
Avg volume
186.9K
Dividend
0.00
IPO
2007-12-27
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about InfuSystem Holdings, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for INFU: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
